These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 22419303)

  • 1. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    Cochrane Database Syst Rev; 2011 Feb; (2):CD005011. PubMed ID: 21328270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Stanworth SJ; Birchall J; Doree CJ; Hyde C
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005011. PubMed ID: 17443565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to decrease blood loss and transfusion requirements for liver transplantation.
    Gurusamy KS; Pissanou T; Pikhart H; Vaughan J; Burroughs AK; Davidson BR
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009052. PubMed ID: 22161443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.
    Fabes J; Brunskill SJ; Curry N; Doree C; Stanworth SJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010649. PubMed ID: 30582172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
    Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
    Desborough M; Hadjinicolaou AV; Chaimani A; Trivella M; Vyas P; Doree C; Hopewell S; Stanworth SJ; Estcourt LJ
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012055. PubMed ID: 27797129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
    Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD009961. PubMed ID: 25922858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
    Iorio A; Matino D; D'Amico R; Makris M
    Cochrane Database Syst Rev; 2010 Aug; (8):CD004449. PubMed ID: 20687076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
    Hayes K; Fernando MC; Jordan V
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013551. PubMed ID: 36408876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials.
    Hsia CC; Chin-Yee IH; McAlister VC
    Ann Surg; 2008 Jul; 248(1):61-8. PubMed ID: 18580208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients.
    Johansen M; Wikkelsø A; Lunde J; Wetterslev J; Afshari A
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010555. PubMed ID: 26151108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
    Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis.
    Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    CMAJ; 2011 Jan; 183(1):E9-19. PubMed ID: 21078742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials.
    Johansson PI
    Vox Sang; 2008 Jul; 95(1):1-7. PubMed ID: 18435677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
    Birschmann I; Klamroth R; Eichler H; Schenk J; Kirchmaier CM; Halimeh S
    Haemophilia; 2013 Sep; 19(5):679-85. PubMed ID: 23647644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
    Matino D; Makris M; Dwan K; D'Amico R; Iorio A
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004449. PubMed ID: 26677005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.